1. Home
  2. WS vs PCRX Comparison

WS vs PCRX Comparison

Compare WS & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WS
  • PCRX
  • Stock Information
  • Founded
  • WS 1955
  • PCRX 2006
  • Country
  • WS United States
  • PCRX United States
  • Employees
  • WS N/A
  • PCRX N/A
  • Industry
  • WS
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WS
  • PCRX Health Care
  • Exchange
  • WS Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • WS 1.3B
  • PCRX 1.2B
  • IPO Year
  • WS N/A
  • PCRX 2011
  • Fundamental
  • Price
  • WS $32.45
  • PCRX $22.90
  • Analyst Decision
  • WS Buy
  • PCRX Buy
  • Analyst Count
  • WS 1
  • PCRX 8
  • Target Price
  • WS $34.00
  • PCRX $28.38
  • AVG Volume (30 Days)
  • WS 376.8K
  • PCRX 545.0K
  • Earning Date
  • WS 06-25-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • WS 1.96%
  • PCRX N/A
  • EPS Growth
  • WS N/A
  • PCRX N/A
  • EPS
  • WS 2.19
  • PCRX N/A
  • Revenue
  • WS $3,093,300,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • WS $1.90
  • PCRX $7.54
  • Revenue Next Year
  • WS $7.23
  • PCRX $10.78
  • P/E Ratio
  • WS $14.88
  • PCRX N/A
  • Revenue Growth
  • WS N/A
  • PCRX 3.08
  • 52 Week Low
  • WS $21.30
  • PCRX $11.16
  • 52 Week High
  • WS $47.19
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • WS 66.58
  • PCRX 35.82
  • Support Level
  • WS $31.11
  • PCRX $22.82
  • Resistance Level
  • WS $32.76
  • PCRX $23.83
  • Average True Range (ATR)
  • WS 1.27
  • PCRX 0.74
  • MACD
  • WS 0.35
  • PCRX -0.02
  • Stochastic Oscillator
  • WS 96.37
  • PCRX 6.22

About WS Worthington Steel Inc.

Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: